WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹173 Cr | ₹109 Cr | ₹64 Cr | ₹67 Cr | ₹160 Cr |
What is the latest Total Debt ratio of WANBURY ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹173 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹67 Cr |
| Mar2021 | ₹160 Cr |
How is Total Debt of WANBURY Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹173 Cr | 58.53 | |
| Mar2024 | ₹109 Cr | 70.37 | |
| Mar2023 | ₹64 Cr | -4.30 | |
| Mar2022 | ₹67 Cr | -58.22 | |
| Mar2021 | ₹160 Cr | - | |
Compare Total Debt of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹888.7 Cr | -1% | -0.4% | 11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹404,468.0 Cr | -1.1% | 1.9% | -8.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,810.0 Cr | 3.5% | 18.2% | 15.4% | Stock Analytics | |
| CIPLA | ₹121,170.0 Cr | -2.6% | -0.9% | -3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,300.0 Cr | -1.3% | 0.8% | 11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,575.0 Cr | 0.2% | -3.5% | -5.8% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1% |
-0.4% |
11.6% |
| SENSEX | -2% |
2.6% |
4.2% |
You may also like the below Video Courses